Literature DB >> 12867019

[Imported hookworm infection in African immigrants in Spain: study of 285 patients].

Carme Roca1, Xavier Balanzó, Goretti Sauca, Josep Lluís Fernández-Roure, Ramon Boixeda, Manel Ballester.   

Abstract

BACKGROUND AND
OBJECTIVE: Hookworm infection is a worldwide intestinal parasitic disease affecting more than one billion people. It represents an important public health problem in rural areas of developing countries. In our environment, it is generally considered an imported disease due to the immigration process. PATIENTS AND
METHOD: Retrospective observational study of African immigrants diagnosed with hookworm infection at the Immigration and Tropical Medicine Unit of the Hospital of Mataró over the period 1984-1999.
RESULTS: We identified 285 patients, mainly young males, from Gambia or Senegal, with a precarious job who had arrived in Spain 3 years earlier or less. Abdominal pain was the commonest reason for consultation (28.8%) cases. Non digestive symptoms were 35.6% and 4.6% remained assymptomatic. 60% had a concomitant infectious disease. Laboratory tests showed iron-deficiency anemia in 28.4% and eosinophilia in 52.3%. 70% of patients did not come to visit after treatment.
CONCLUSIONS: Microbiologic stool examination is recommended as part of the health assessment of immigrants from countries where hookworm infection is highly prevalent, even in the absence of abdominal symptoms or abnormalities of the red and white blood series.

Entities:  

Mesh:

Year:  2003        PMID: 12867019     DOI: 10.1016/s0025-7753(03)73883-4

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

1.  Study of the Use of Antinematode Drugs, Mebendazole and Pyrantel, in Galicia (Spain) from 2016 to 2020.

Authors:  S Vázquez-Prieto; A Vaamonde; E Paniagua
Journal:  J Parasitol Res       Date:  2022-09-13

Review 2.  [Imported infectious diseases in Spain].

Authors:  Gerardo Rojo Marcos; Juan Cuadros González; Alberto Arranz Caso
Journal:  Med Clin (Barc)       Date:  2008-10-25       Impact factor: 1.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.